Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Rebouissou

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oncoimmunology|May 10, 2019
<i>APC</i> germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structuresGuillaume Morcrette, Theo Z Hirsch, Elise Badour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2017
Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity <i>In Vitro</i>Sandra Rebouissou, Tiziana La Bella, Samia Rekik, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Cell Reports|December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypesAnne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
Journal of Hepatology|December 18, 2020
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetMassih Ningarhari, Stefano Caruso, Théo Z Hirsch, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCCJessica Zucman-Rossi, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, et al.
Gastroenterology|May 8, 2019
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of ResponseStefano Caruso, Anna-Line Calatayud, Jill Pilet, et al.
Nature Communications|May 19, 2026
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypesLong Pan, Théo Z Hirsch, Jing Fang, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oncoimmunology|May 10, 2019
<i>APC</i> germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structuresGuillaume Morcrette, Theo Z Hirsch, Elise Badour, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2017
Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity <i>In Vitro</i>Sandra Rebouissou, Tiziana La Bella, Samia Rekik, et al.
The Journal of Pathology|March 17, 2012
CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinomaSandra Rebouissou, Aurélie Hérault, Eric Letouzé, et al.
Cell Reports|December 3, 2014
Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypesAnne Biton, Isabelle Bernard-Pierrot, Yinjun Lou, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
Journal of Hepatology|December 18, 2020
Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic targetMassih Ningarhari, Stefano Caruso, Théo Z Hirsch, et al.
Hepatology (Baltimore, Md.)|February 24, 2006
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCCJessica Zucman-Rossi, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, et al.
Gastroenterology|May 8, 2019
Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of ResponseStefano Caruso, Anna-Line Calatayud, Jill Pilet, et al.
Nature Communications|May 19, 2026
Integrated genomic analyses identify oncogenic pathway interplay in hepatocarcinogenesis defining specific molecular subtypesLong Pan, Théo Z Hirsch, Jing Fang, et al.
Cell Metabolism|February 5, 2019
Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin MutationsAdeola O Adebayo Michael, Sungjin Ko, Junyan Tao, et al.
Pageof 5